Colt:
Firstly I'll have you note that I'm not a medically trained person. Obviously I'm happy for anyone qualified to correct my interpretation.
I understand from the literature that 68Ga-labeled prostate-specific membrane antigen (PSMA-11) PET/CT detects recurrent prostate cancer with sensitivity superior to standard-of-care imaging. So this trial (of a relatively small sample of 25 men selected) compared the results of the baseline 68Ga analysis to the results using 64Cu SAR-bombesin.
A considerable number of the patients were found to have negative results based on 68Ga but 64Cu demonstrated sites of disease recurrence in 44% of those negative cases. This adds further weight to the suggestion that 64Cu is a superior diagnostic tool for the detection of prostate cancer in certain instances.
- Forums
- ASX - By Stock
- CU6
- Research/Valuation
Research/Valuation, page-588
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.78 |
Change
0.270(4.15%) |
Mkt cap ! $2.169B |
Open | High | Low | Value | Volume |
$6.63 | $6.88 | $6.60 | $11.91M | 1.752M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1600 | $6.77 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.80 | 2400 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1600 | 6.770 |
1 | 7114 | 6.720 |
4 | 17408 | 6.700 |
2 | 50088 | 6.690 |
2 | 7114 | 6.670 |
Price($) | Vol. | No. |
---|---|---|
6.800 | 2400 | 2 |
6.830 | 7114 | 1 |
6.840 | 7114 | 1 |
6.850 | 4731 | 1 |
6.860 | 7114 | 1 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |